[Treatment of malaria: outlook].
Prospects for new and effective antimalarial treatments have improved significantly in the past few years. There are more funds, new operational paradigms and actors, and more products in the pipeline. However, the limited novelty of the products currently in clinical development means that more emphasis therefore needs to be placed on the discovery of novel chemical entities to achieve effective, sustainable control. The development and deployment of new products is both lengthy and complex.
Olliaro
Piero
P
olliarop@who.int
Brasseur
Philippe
P
D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000191:economics; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy*; D012109:Research Support as Topic; D012717:Sesquiterpenes / Q000008:administration & dosage / Q000627:therapeutic use
D000962:Antimalarials; D037621:Artemisinins; D007783:Lactones; D012717:Sesquiterpenes; C075875:artemisin